ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,576.00
0.08%
S&P ASX All Technology
2,969.60
0.03%
Brent Oil
83.565
0.03%
US Dollar vs AUD
1.53253
0.10%
Bitcoin
57,743.21
-0.85%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Tempest Therpeutics Inc (TPST)

  7. Tempest Therpeutics Inc (TPST) News

TPST Tempest Therpeutics Inc

3.70
0.23 (6.63%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Tempest Therpeutics Inc TPST NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.23 6.63% 3.70 09:53:23
Open Price Low Price High Price Close Price Previous Close
3.47 3.4201 3.67 3.62 3.47
more quote information »

Recent News

Date Time Source Heading
27/4/202406:05GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
09/4/202422:00GLOBETempest Reports New Preclinical Data for TPST-1120 in RCC at..
04/4/202423:00GLOBETempest Announces Publication of Positive Data from Phase 1..
20/3/202407:25GLOBETempest Reports Year End 2023 Financial Results and Provides..
12/3/202423:00GLOBETempest Presents New Data at the SITC 2024 Spring Scientific..
06/3/202408:30GLOBETempest Announces Upcoming Presentation of Preclinical Data..
27/2/202400:00GLOBETempest to Present at the 44th Annual TD Cowen Healthcare..
15/2/202410:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202406:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202409:41EDGAR2Form SC 13D/A - General statement of acquisition of..
03/2/202408:30GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
06/1/202408:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202408:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202408:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202408:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202408:05GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
02/12/202308:15GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
21/11/202300:00GLOBETempest to Present at the 35th Annual Piper Sandler..
18/11/202308:46EDGAR2Form S-8 POS - Securities to be offered to employees in..
18/11/202308:45EDGAR2Form S-8 POS - Securities to be offered to employees in..
18/11/202308:44EDGAR2Form S-8 POS - Securities to be offered to employees in..
18/11/202308:44EDGAR2Form S-8 POS - Securities to be offered to employees in..
18/11/202308:43EDGAR2Form S-8 POS - Securities to be offered to employees in..
18/11/202308:39EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/11/202309:28EDGAR2Form SC 13D/A - General statement of acquisition of..
09/11/202309:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202309:18EDGAR2Form 8-K - Current report
09/11/202309:17GLOBETempest Reports Third Quarter 2023 Financial Results and..
03/11/202307:16EDGAR2Form 144 - Report of proposed sale of securities
30/10/202321:06EDGAR2Form 8-K - Current report
14/10/202307:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/10/202307:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/10/202307:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/10/202307:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202321:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/10/202323:29EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
11/10/202323:13EDGAR2Form 8-K - Current report
11/10/202323:01GLOBETempest Adopts Limited Duration Stockholder Rights Plan
11/10/202323:00GLOBETempest Releases New Data Demonstrating Superiority of..
11/10/202307:05GLOBETempest to Report New and Updated Data from Global..
19/9/202322:00GLOBETempest Announces Expanded Role for Sam Whiting, M.D.,..
09/9/202306:16EDGAR2Form 8-K - Current report
08/9/202306:19EDGAR2Form 8-K - Current report
05/9/202322:00GLOBETempest to Present at the H.C. Wainwright 25th Annual Global..
11/8/202306:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202306:27EDGAR2Form 8-K - Current report
11/8/202306:13GLOBETempest Reports Second Quarter 2023 Financial Results and..
19/7/202322:00GLOBETempest Announces Publication in Cancer Research..
01/6/202306:05GLOBETempest to Present at the Jefferies Global Healthcare..
26/5/202307:00GLOBETempest to Present Phase 1 Monotherapy and Combination Data..

Your Recent History

NASDAQ
TPST
Tempest Therpeutics
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved